drugset / Trial / NCT07009353

A Study to Learn How the Study Medicine Called [14C]PF-07054894 is Processed by the Body

NCT07009353 ↗

Phase 1 Completed 10 enrolled Pfizer
Non-randomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to learn how quickly and to what extent the study medicine (PF-07054894) is absorbed, broken down, and eliminated from the body.

Timeline

Start
2025-06-20
Primary completion
2025-08-20
Completion
2025-09-11

Drugs

EvaluationDrugModalityDoseRoute
Subject PF-07054894 Small molecule — Oral

Indications

No indication recorded.